MedPath

Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction

Not Applicable
Conditions
Malignant Tumor
Interventions
Device: Stenting by ERCP (endoscopic retrograde cholangiopancreatography)
Device: SEMS(self-expandable metallic stent)
Registration Number
NCT02937246
Lead Sponsor
Yonsei University
Brief Summary

Previous studies indicated that covered stents are less likely to become occluded in comparison to bare stents. While the probability of occlusions caused by tumor in-growth is less in covered stents, they are more likely to spontaneously migrate to a position that is distal to the original deployment site. However, newer covered stents with improved designs, such as the partially covered double bare metallic stent used for this study, include features to mitigate the migration issue. The purpose of this study is to confirm whether the difference in patency rate between regular covered stents and bare stents, which has already been well established by existing studies, is also reproducible when double covered stents are compared against double bare stents.

Detailed Description

Malignant obstructive jaundice is a common complication of advanced stage cholangiocarcinoma, GB cancer, and pancreatic cancer. In biliary stricture by malignancy, biliary drainage with placement of self-expanding metal stent (SEMS) for palliation is the therapy of choice in these patients. When compared to plastic stents, SEMS present a significantly decreased risk of recurrent biliary obstruction. SEMS are also more cost-effective than plastic stents in patients with a life expectancy of longer than 4 months. However, despite their numerous benefits, SEMS become occluded in up to 50 % of patients in the first 6-8 months. In order to minimize the occurrence of this issue, covered stents were developed. Previous studies indicated that covered stents are less likely to become occluded in comparison to bare stents. While the probability of occlusions caused by tumor in-growth is less in covered stents, they are more likely to spontaneously migrate to a position that is distal to the original deployment site. However, newer covered stents with improved designs, such as the partially covered double bare metallic stent used for this study, include features to mitigate the migration issue. The purpose of this study is to confirm whether the difference in patency rate between regular covered stents and bare stents, which has already been well established by existing studies, is also reproducible when double covered stents are compared against double bare stents.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
260
Inclusion Criteria
  • Pathologically confirmed malignant biliary obstruction or clinically defined malignant biliary obstruction
  • malignant biliary obstruction was located more than 1cm from the hilum
  • older than 20 years old
  • Life expectancy > 6 months
  • Inoperable case due to advanced stage or comorbidity
  • Informed consent obtained
Read More
Exclusion Criteria
  • Inadequate case for ERCP
  • Failed endoscopic approach to duodenum or biliary tract
  • biliary obstruction was located at hilum or IHD
  • patients with uncontrolled infection
  • Pregnancy
  • No signed informed consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
the control groupStenting by ERCP (endoscopic retrograde cholangiopancreatography)Uncovered double bare metal stent
the intervention groupSEMS(self-expandable metallic stent)Partial covered double bare metal stent
Primary Outcome Measures
NameTimeMethod
Mean duration of stent patency6 months after stenting

Check the duration until the date of obstruction of inserted stent within 6 months after stenting

Secondary Outcome Measures
NameTimeMethod
Patency rate of stent6 months after stenting
Overall survival6 months after stenting

Trial Locations

Locations (1)

Severance Hospital, Yonsei University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath